How to Use SPACE2 Online
Try SPACE2
Commercially Available Online Web Server
SPACE2: A New Tool for Epitope Profiling and Antibody Design
SPACE2, a computational tool for improved epitope profiling that accurately groups antibodies that bind to the same epitope. It builds upon previous methods by utilizing modern machine learning-based structure prediction technology and a new clustering protocol. SPACE2 is a significant advancement for antibody discovery, as it can identify functional convergence in antibodies with highly dissimilar sequences and different genetic origins, a major limitation of traditional sequence-based methods.
How SPACE2 Works
SPACE2's core innovation is a new clustering protocol that combines sequence and structural data to accurately group antibodies that bind to the same epitope.
Structure-Based Clustering: The tool leverages state-of-the-art machine learning structure prediction models, such as AlphaFold, to incorporate structural information into its analysis. This structural data provides orthogonal information that significantly improves the ability to identify antibodies that bind to the same epitope, even when their sequences are highly dissimilar.
High-Resolution Profiling: The model's clustering of antibodies that bind to the same residue-level epitope is so precise that its resolution is comparable to that of crystal structures.
Scalability: SPACE2 achieves much higher dataset coverage compared to previous methods like its predecessor, SPACE1, and a variety of sequence-based methods, making it a scalable solution for large-scale antibody profiling.
What is Tamarind Bio?
Tamarind Bio is a pioneering no-code bioinformatics platform built to democratize access to powerful computational tools for life scientists and researchers. Recognizing that many cutting-edge machine learning models are often difficult to deploy and use, Tamarind provides an intuitive, web-based environment that completely abstracts away the complexities of high-performance computing, software dependencies, and command-line interfaces.
The platform is designed provide easy access to biologists, chemists, and other researchers who may not have a background in programming or cloud infrastructure but want to run experimental models with their data. Key features include a user-friendly graphical interface for setting up and launching experiments, a robust API for integration into existing research pipelines, and an automated system for managing and scaling computational resources. By handling the technical heavy lifting, Tamarind empowers researchers to concentrate on their scientific questions and accelerate the pace of discovery.
Accelerating Discovery with SPACE2 on Tamarind Bio
Using SPACE2 on a platform like Tamarind would accelerate antibody discovery and lead optimization by providing a powerful, high-resolution tool for epitope profiling.
Rapid Epitope Mapping: Researchers could use the platform to quickly analyze a large set of antigen-specific antibodies and group them by epitope. This helps to identify antibodies that bind to the same target and provides a clearer picture of an immune response.
De Novo Antibody Design: By identifying antibodies that converge on the same epitope despite having different sequences and origins, SPACE2 can guide the design of new antibodies that are not limited by existing frameworks, enabling the creation of novel therapeutics.
Accessible Workflow: By integrating SPACE2's computationally intensive clustering protocol into a no-code platform, Tamarind would make advanced epitope profiling accessible to a wider range of researchers, democratizing access to cutting-edge tools and accelerating scientific progress.
How to Use SPACE2 on Tamarind Bio
To leverage SPACE2's power, a researcher could follow this streamlined workflow on Tamarind:
Access the Platform: Begin by logging in to the tamarind.bio website.
Select SPACE2: From the list of available computational models, choose the SPACE2 tool.
Input Antibody Sequences: Provide a set of antibody sequences and the corresponding antigen.
Run SPACE2: The platform would run the SPACE2 tool, which would use its structure prediction and clustering protocol to group the antibodies based on their predicted binding epitope.
Analyze and Interpret: The output provides a set of antibody clusters, each corresponding to a specific epitope. You can then analyze the sequences and structures within each cluster to understand the key features of the binding interaction and guide the design of new antibodies.